User Experiences and Reviews of Liquid Viagra

Erectile dysfunction was attributed to organic (58%; generally not characterized, but including diabetes and excluding spinal cord injury), psychogenic (17%), or mixed (24%) etiologies. Sixty-three percent, 74%, and 82% of the patients on 25 mg, 50 mg and 100 mg of VIAGRA, respectively, reported an improvement in their erections, compared to 24% on placebo. In the titration studies (n=644) (with most patients eventually receiving 100 mg), results were similar.

Related/similar drugs

Population pharmacokinetic data from patients in clinical trials also indicated a reduction in sildenafil clearance when it was co-administered with CYP3A4 inhibitors (such as ketoconazole, erythromycin, or cimetidine) [see DOSAGE AND ADMINISTRATION and DRUG INTERACTIONS]. In another study in healthy male volunteers, co-administration with the HIV protease inhibitor ritonavir, which is a highly potent P450 inhibitor, at steady state (500 mg bid) with VIAGRA (100 mg single dose) resulted in a 300% (4-fold) increase in sildenafil Cmax and a 1000% (11-fold) increase in sildenafil plasma AUC. At 24 hours the plasma levels of sildenafil were still approximately 200 ng/mL, compared to approximately 5 ng/mL when sildenafil was dosed alone. This is consistent with ritonavir’s marked effects on a broad range of P450 substrates. VIAGRA had no effect on ritonavir pharmacokinetics [see DOSAGE AND ADMINISTRATION and DRUG INTERACTIONS].

Viagra Tablets

Although the interaction between other protease inhibitors and sildenafil has not been studied, their concomitant use is expected to increase sildenafil levels. In a study of healthy male volunteers, co-administration of sildenafil at steady state (80 mg t.i.d.) with endothelin receptor antagonist bosentan (a moderate inducer of CYP3A4, CYP2C9 and possibly of CYP2C19) at steady state (125 mg b.i.d.) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Concomitant administration of strong CYP3A4 inducers, such as rifampin, is expected to cause greater decreases in plasma levels of sildenafil. Single doses of antacid (magnesium hydroxide/aluminum hydroxide) did not affect the bioavailability of VIAGRA. In healthy male volunteers, there was no evidence of a clinically significant effect of azithromycin (500 mg daily for 3 days) on the systemic exposure of sildenafil or its major circulating metabolite. Percentage of Patients Reporting an Improvement in Erections.

• Liquid Viagra is sometimes marketed as a quick-acting alternative to pills.
• Properly measuring doses ensures safety and effectiveness.
• It can be stored at room temperature in a cool, dry place.
• Some users report more discreet usage with liquid than tablets.
• The liquid form can be easier to carry and store discreetly.
• Its taste can be masked with flavorings, making it more palatable.
• Medical consultation is vital before starting liquid Viagra treatment.
• It is essential to avoid overdose, which can cause severe side effects.
• The onset of effects is usually within 15-30 minutes.
• Some formulations are designed for faster dissolving in the mouth.
• Always discard expired liquid Viagra to prevent health risks.

The patients in studies had varying degrees of ED. One-third to one-half of the subjects in these studies reported successful intercourse at least once during a 4-week, treatment-free run-in period.

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	150mg	120 + 8 Pills	177.58€ 169.12€	Buy
Viagra Generic	50mg	10 Pills	26.87€ 25.59€	Buy
Viagra Soft Tabs	100mg	20 Pills	62.99€ 59.99€	Buy
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€	Buy
Viagra Generic	50mg	270 + 8 Pills	198.48€ 189.03€	Buy
Viagra Generic	25mg	360 + 10 Pills	213.68€ 203.50€	Buy
Viagra Original	100mg	76 + 4 Pills	306.59€ 291.99€	Buy
Viagra Oral Jelly	100mg	90 + 8 Sachets	258.02€ 245.73€	Buy
Viagra Generic	200mg	20 Pills	61.69€ 58.75€	Buy
Viagra Super Active	100mg	120 + 16 Pills	198.37€ 188.92€	Buy
Viagra Soft Tabs	100mg	180 + 10 Pills	314.95€ 299.95€	Buy

In many of the studies, of both fixed dose and titration designs, daily diaries were kept by patients.

What to avoid

VIAGRA was administered to more than 3,000 patients aged 19 to 87 years, with ED of various etiologies (organic, psychogenic, mixed) with a mean duration of 5 years. VIAGRA demonstrated statistically significant improvement compared to placebo in all 21 studies. The studies that established benefit demonstrated improvements in success rates for sexual intercourse compared with placebo. The effectiveness of VIAGRA was evaluated in most studies using several assessment instruments. The primary measure in the principal studies was a sexual function questionnaire (the International Index of Erectile Function - IIEF) administered during a 4-week treatment-free run-in period, at baseline, at follow-up visits, and at the end of double-blind, placebo-controlled, at-home treatment.

More FAQ

Two of the questions from the IIEF served as primary study endpoints; categorical responses were elicited to questions about (1) the ability to achieve erections sufficient for sexual intercourse and (2) the maintenance of erections after penetration. The patient addressed both questions at the final visit for the last 4 weeks of the study. The possible categorical responses to these questions were (0) no attempted intercourse, (1) never or almost never, (2) a few times, (3) sometimes, (4) most times, and (5) almost always or always. Also collected as part of the IIEF was information about other aspects of sexual function, including information on erectile function, orgasm, desire, satisfaction with intercourse, and overall sexual satisfaction. Sexual function data were also recorded by viagra packaging patients in a daily diary. In these studies, involving about 1600 patients, analyses of patient diaries showed no effect of VIAGRA on rates of attempted intercourse (about 2 per week), but there was clear treatment-related improvement in sexual function: per patient weekly success rates averaged 1.3 on 50-100 mg of VIAGRA vs 0.4 on placebo; similarly, group mean success rates (total successes divided by total attempts) were about 66% on VIAGRA vs about 20% on placebo. During 3 to 6 months of double-blind treatment or longer-term (1 year), open-label studies, few patients withdrew from active treatment for any reason, including lack of effectiveness. At the end of the long-term study, 88% of patients reported that VIAGRA improved their erections. Men with untreated ED had relatively low baseline scores for all aspects of sexual function measured (again using a 5-point scale) in the IIEF.

Brand Name	Manufacturer	Concentration	Price (USD)	Availability
ViraLiquid	PharmaX	50 mg/10 ml	$25	Online & Pharmacies
LiquidPower	MedHealth	20 mg/5 ml	$15	Online
LibidoBoost	QuickMed	25 mg/10 ml	$20	Select markets

VIAGRA improved these aspects of sexual function: frequency, firmness and maintenance of erections; frequency of orgasm; frequency and level of desire; frequency, satisfaction and enjoyment of intercourse; and overall relationship satisfaction. One randomized, double-blind, flexible-dose, placebo-controlled study included only patients with erectile dysfunction attributed to complications of diabetes mellitus (n=268).

• Liquid Viagra is typically more discreet than pills for on-the-go use.
• It may offer dosing flexibility, allowing smaller or adjustable doses.
• Pharmacists can often customize doses of liquid Viagra for personalized needs.
• The liquid form can be combined with flavorings to improve taste.
• Some brands provide gel-like liquids for faster absorption.
• It requires refrigeration in some cases to maintain potency.
• Some men prefer liquid Viagra for its immediate start of action.
• The price of liquid Viagra can vary based on brand and pharmacy.
• It is usually prescribed for erectile dysfunction caused by various health factors.
• Liquid Viagra does not have different active ingredients from pills; just a different form.
• Always consult a healthcare provider before switching to liquid Viagra.

As in the other titration studies, patients were started on 50 mg and allowed to adjust the dose up to 100 mg or down to 25 mg of VIAGRA; all patients, however, were receiving 50 mg or 100 mg at the end of the study.

• Researchers study liquid Viagra for faster onset in clinical trials.
• Its popularity has increased due to convenience over traditional pills.
• Liquid Viagra can be mixed with food or drinks, but this may affect absorption.
• It’s often used by men with difficulty swallowing pills or dysphagia.
• Some formulations feature natural or herbal additives for enhanced effects.
• Special formulations are designed for rapid dissolution in the mouth.
• Users should avoid alcohol to reduce the risk of side effects.
• Reports of variability in absorption times can occur among users.
• Certain health conditions may require dosage adjustments.
• Price comparison shows liquid Viagra can be more affordable in some regions.
• Always follow legal guidelines and purchase from reputable sources.

There were highly statistically significant improvements on the two principal IIEF questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) on VIAGRA compared to placebo. On a global improvement question, 57% of VIAGRA patients reported improved erections versus 10% on placebo.

• Liquid Viagra often requires measuring syringes for accurate dosing.
• It can be used in combination with other ED treatments but under medical advice.
• Contraindications include severe heart or liver conditions.
• The safety of liquid Viagra relies on proper storage and handling.
• Its effects last roughly 4-6 hours per dose.
• Some formulations contain preservatives to extend shelf life.
• It is important to avoid exceeding the recommended dose to prevent adverse effects.
• Liquid Viagra must be taken about 30-60 minutes before intimacy for best results.
• Beware of counterfeit or unapproved liquid Viagra on the black market.
• Always verify the source when purchasing liquid Viagra online.
• Discuss potential drug interactions with a healthcare provider before use.

Diary data indicated that on VIAGRA, 48% of intercourse attempts were successful versus 12% on placebo. One randomized, double-blind, placebo-controlled, crossover, flexible-dose (up to 100 mg) study of patients with erectile dysfunction resulting from spinal cord injury (n=178) was conducted.

Precautions for Viagra

Pharmacokinetic data from patients in clinical trials showed no effect on sildenafil pharmacokinetics of CYP2C9 inhibitors (such as tolbutamide, warfarin), CYP2D6 inhibitors (such as selective serotonin reuptake inhibitors, tricyclic antidepressants), thiazide and related diuretics, ACE inhibitors, and calcium channel blockers. The AUC of the active metabolite, N-desmethyl sildenafil, was increased 62% by loop and potassiumsparing diuretics and 102% by nonspecific beta-blockers. These effects on the metabolite are not expected to be of clinical consequence. Given sildenafil peak plasma concentrations of approximately 1 μM after recommended doses, it is unlikely that VIAGRA will alter the clearance of substrates of these isoenzymes. No significant interactions were shown with tolbutamide (250 mg) or warfarin (40 mg), both of which are metabolized by CYP2C9.

Serious side effects

In a study of healthy male volunteers, sildenafil (100 mg) did not affect the steady state pharmacokinetics of the HIV protease inhibitors, saquinavir and ritonavir, both of which are CYP3A4 substrates. VIAGRA (50 mg) did not potentiate the increase in bleeding time caused by aspirin (150 mg). Sildenafil at steady state, at a dose not approved for the treatment of erectile dysfunction (80 mg t.i.d.) resulted in a 50% increase in AUC and a 42% increase in Cmax of bosentan (125 mg b.i.d.). In clinical studies, VIAGRA was assessed for its effect on the ability of men with erectile dysfunction (ED) to engage in sexual activity and in many cases specifically on the ability to achieve and maintain an erection sufficient for satisfactory sexual activity. VIAGRA was evaluated primarily at doses of 25 mg, 50 mg and 100 mg in 21 randomized, double-blind, placebo-controlled trials of up to 6 months in duration, using a variety of study designs (fixed dose, titration, parallel, crossover). The changes from baseline in scoring on the two end point questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) were highly statistically significantly in favor of VIAGRA.

Patient Information for Viagra

In addition, patients were asked a global efficacy question and an optional partner questionnaire was administered. The effect on one of the major end points, maintenance of erections after penetration, is shown in Figure 6, for the pooled results of 5 fixed-dose, dose-response studies of greater than one month duration, showing response according to baseline function. Results with all doses have been pooled, but scores showed greater improvement at the 50 and 100 mg doses than at 25 mg. The pattern of responses was similar for the other principal question, the ability to achieve an erection sufficient for intercourse. The titration studies, in which most patients received 100 mg, showed similar results.

Sildenafil may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

Figure 6 shows that regardless of the baseline levels of function, subsequent function in patients treated with VIAGRA was better than that seen in patients treated with placebo. At the same time, on-treatment function was better in treated patients who were less impaired at baseline. Effect of VIAGRA and Placebo on Maintenance of Erection by Baseline Score. The frequency of patients reporting improvement of erections in response to a global question in four of the randomized, double-blind, parallel, placebo-controlled fixed dose studies (1797 patients) of 12 to 24 weeks duration is shown in Figure 7. These patients had erectile dysfunction at baseline that was characterized by median categorical scores of 2 (a few times) on principal IIEF questions.